Psy105 - Cost-Utility of Nintedanib Versus Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis: A Belgian Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search